Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma

BACKGROUND: Autologous stem cell transplantation (ASCT) is the standard treatment strategy for refractory or relapsed classical Hodgkin lymphoma (R/R cHL). However, a single transplantation is insufficient to cure the disease because of unfavorable risk factors. Herein, we evaluated the outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Deng, Jili, Xie, Yan, Mi, Lan, Liu, Weiping, Wang, Xiaopei, Zhao, Linjun, Song, Yuqin, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225219/
https://www.ncbi.nlm.nih.gov/pubmed/37081731
http://dx.doi.org/10.1002/cam4.5765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225219/
https://www.ncbi.nlm.nih.gov/pubmed/37081731
http://dx.doi.org/10.1002/cam4.5765

Ejemplares similares